Pulmozyme

Medicinal product

(Invented) name

Pulmozyme

Active substance (s)

Dornazė alfa

Strength

2500 TV/2,5 ml

Pharmaceutical form

purškiamasis įkvepiamasis tirpalas

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R05CB13, Dornase alfa (desoxyribonuclease)

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-08-13

Date of renewal

Documents

2771_Pulmozyme 2500 TV2,5 ml puršk įkv tirp_PL_2025-08-13.docx

2771_Pulmozyme 2500 TV2,5 ml puršk įkv tirp_PZ_2025-08-13.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Ampulėje (2,5 ml) yra	2.5 ml
Dornazė alfa	2500 TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118318	104423	1104423	ampulė	2,5 ml, N6		Receptinis	LT/L/25/2771/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-08-13	Registruotas